Program

Practical guidance diabetes management - introductory talk 
(speaker to be confirmed)

Practical guidance diabetes management - introductory talk 
(speaker to be confirmed)

22 November

08:30Registration & walk-in coffee
 
09:00Workshop opening
 Session 1: Natural history and epidemiology
09:10Colombo, Massimo 2011Natural history of NASH
Massimo Colombo, MD
Humanitas Research Hospital, Rozzano, Italy
  
09:30

Razavi, Homie 2017 120NASH epidemiology
Homie Razavi, PhD
Center for Disease Analysis (CDA), Louisville, CO, USA

09:50Gender neutral avatar 120x160NASH diagnosis and management in general practice
Rachel Pryke, MBBS MRCGP FRCP
Winyates Health Centre, United Kingdom
10:10Panel Discussion
10:45Coffee break
 Session 2: Clinical management of NASH - obesity and diabetes management
11:15Practical guidance obesity management - introductory talk 
(speaker to be confirmed)
11:35Clinical case discussion
 11:55Practical guidance diabetes management - introductory talk 
(speaker to be confirmed)
12:15Clinical case discussion
  
12:35Lunch & Poster viewing
  
 Session 3: Clinical Management of NASH - Special Populations
13:45Gender neutral avatar 120x160Management of lean NASH
Javier Ampuero, MD, PhD
Hospital Universitario Virgen del Rocío, Seville, Spain
14:05

Baker, Alastair 2019Pediatric NAFLD 
Alastair Baker, MB, ChB, FRCP, FRCPCH, MBA
King's College Hospital NHS Foundation Trust, United Kingdom

 14:25

Gender neutral avatar 120x160NASH in HIV
Berend van Welzen, MD
UMC Utrecht, the Netherlands

14:45 Coffee break
 Session 4: NASH Management
15:15

Manuel Romero-Gomez, MDUniversity of Seville, Spain

New biomarkers in NAFLD
Manuel Romero - Gomez, MD
University of Seville, Spain

15:35Zelber-Sagi Shira, 2018How to implement a healthy lifestyle in NAFLD/NASH patients
Shira Zelber-Sagi, PhD
Tel Aviv Sourasky Medical Center, Israel
16:55Roundtable Discussion: The interface of primary and secondary care
Moderator: Emmanouil Tsochatzis, MD, PhD, Royal Free Hospital, United Kingdom
  
16:30Open Poster Session & Welcome Reception
19:30Workshop Dinner

23 November

 Session 5: NASH and comorbidities
09:00Gender neutral avatar 120x160NASH/NAFLD as cause for HCC
Helen Reeves, MD, PhD
Newcastle Universtity, United Kingdom
09:20Gender neutral avatar 120x160Drug-induced liver injury and NASH
Raúl Andrade, ND, PhD
University Hospital Virgen de la Victoria, Malaga, Spain
09:40Schattenberg,Joern 2018Cardiovascular risk in NAFLD
Jörn M. Schattenberg, MD
Johannes Gutenberg-Universität Mainz, Germany
 
10:00Gender neutral avatar 120x160NASH and immune-mediated diseases
Maria Teresa Arias-Loste, MD
Hospital Universitario Marques de Valdecilla, Santander, Spain
10:00Roundtable discussion: Current guidelines - still relevant or in need for review?
10:30Coffee break
 Session 6: NASH drug development
11:00What's in the pipeline? Industry presentations
12:00Lunch
 Session 7: Future treatment and management options
13:00

Vlad Ratziu, MD, PhDUniversity of Pierre and Marie Curie, Paris, France

Invited Lecture
Vlad Ratziu, MD, PhD 
Pierre and Marie Curie University, Paris, France

13:20Patient perspective
(speaker to be confirmed)
13:40Roundtable discussion: Current challenges and future trends
14:30Closing remarks
14:40Closure of the Workshop